Searched for
FOSUN
After AI, China unicorns are eyeing global domination in robotic humanoidsLinkerbot currently holds over 80 per cent of the global market share in high-degree-of-freedom (DoF) robotic hands.- Bay Capital launches digital fund, appoints Sandeep Barasia, Tej Kapoor as partnersBay Capital is launching a Digital Opportunities Fund to invest in public and private digital businesses in India. Sandeep Barasia and Tej ...
- Fosun to pare stake in Gland PharmaShanghai-based Fosun Pharmaceutical Group, the promoter of Gland Pharma, plans to sell up to a 5% stake in the company through a block deal...
- Fosun likely to sell 5% stake in Gland PharmaFosun will sell the shares at Rs 1750 per share which is 4.9% discount to the last traded price of Rs 1839.65. Fosun currently has a 57.86 ...
- Fosun is said to plan block deals to pare stake in Gland PharmaThe listed arm of billionaire Guo Guangchang’s Fosun International Ltd. holds about 58% of Gland Pharma, which has a market value 303 billi...
- Fosun drops plan to sell stake in Gland Pharma: ReportShares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had ...
- Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
- Fosun Said to Mull Sale of India’s $3.6 Billion Gland PharmaA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- Gland Pharma rallies 9% as Fosun mulls selling controlling stake in firmA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- Chinese biz major Fosun donates masks to India to fight Covid-19The first batch of medical protective supplies to India, 5,000 pieces of surgical masks that were cleared for use in the “red zone” of hosp...
- Fosun closes deals across sectors; Leads $12 million round in LetsTransportVC arm invests $5 million in Bengaluru-based firm marking its second bet in logistics sector.
- China’s Fosun emerges as the fourth contender for cash-strapped Fortis healthcareChina's Fosun has assets of $75 billion and an existing investment in India’s Gland Pharma, which it purchased from US buyout giant KKR.
- Fosun targets Fortis: A white knight or a dark horse?Often known as China's Warren Buffett, Guo Guangchang prefers to be his student instead. His mysterious disappearance last year raised many...
- China’s Fosun eyes stake in Ahuja ConstructionsThe Fosun Group is amongst China’s largest privately-owned investment conglomerates with interests spanning across pharmaceuticals, real es...
- Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 billionFosun Pharma and Fosun International indirectly hold approximately 74 per cent equity interest in Gland Pharma, the joint statement added.
- Gland Pharma's deal with Fosun will open up new markets: Ravi Penmetsa, MD, Gland PharmaThe deal with Fosun is also an example of the excellence of India’s manufacturing capabilities. It goes with the essence of the Make in Ind...
- Fosun agrees to buy KKR-backed Gland Pharma for $1.4 billion: SourceThe deal would be the first major move by the Fosun group since Guo Guangchang, founder of flagship holding firm Fosun International Ltd an...
- China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billionShanghai Fosun will acquire the shares held by Gland Pharma founders Ravi Penmetsa and his family and PE giant KKR.
- China's Fosun to buy KKR backed Gland Pharma for $1.4 billionFosun has agreed to acquire 96 percent stake, which includes shares held by founders of Gland Pharma Ravi Penmetsa and family and private e...
- Fosun leads the race to buy Gland Pharma with $1.27 billion bidComing from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-l...
Load More
